hoodb.com

アンジェス Research Memo(5):ARDS治療薬は25/12期下期に前期第2相臨床試験の被験者登録完了目指す(フィスコ)

|

You are leaving and open the following URL" of about " 5" news

news.google.com/rss/articles/CBMihwFBVV95cUxObExuYzdZc0UyRGswT2FCR0hUVlozRFdqRl8tR3hSQVdJQ0lkRWtwMXNGQkR3dm9CaGhkckhOMFIzSmNtM1lYZjlscXlUZnIwSVdpWkZSSi1jQWxZT1FEanRRamoySEh2bk40ZlRsYjluNDF2dFc0Mk5kSmFsVHRJN1loVkJQRW8?oc=5


Continue Opne >

5: アンジェス Research Memo(5):ARDS治療薬は25/12期下期に前期第2相臨床試験の被験者登録完了目指す(フィスコ)


More 5 news:



Warning: filemtime(): stat failed for aCache/aaa/gnews/JP/ 5.xml in /var/www/hoodb/function.php on line 339
1737009755-
Warning: file_put_contents(aCache/aaa/gnews/JP// 5.xml): Failed to open stream: No space left on device in /var/www/hoodb/function.php on line 348

About 5

from
1737009755-1736892677

Warning: filemtime(): stat failed for aCache/search/jp/ 5 in /var/www/hoodb/function.php on line 339
1737009755-

5, アンジェス Research Memo(5):ARDS治療薬は25/12期下期に前期第2相臨床試験の被験者登録完了目指す(フィスコ) 2022 5

アンジェス Research Memo(5):ARDS治療薬は25/12期下期に前期第2相臨床試験の被験者登録完了目指す(フィスコ)

Choose Your Country or Region


Back to Top



アンジェス Research Memo(5):ARDS治療薬は25/12期下期に前期第2相臨床試験の被験者登録完了目指す(フィスコ)

Copyright © 2020-2021 hoodb.com. All Rights Reserved.